Skip to main content

Table 2 Demographic description of datasets

From: A comparison of predictors for mortality and bacteraemia in patients suspected of infection

 

SLB

HvH

TREAT04

Overall

Patients, n

199

263

1354

1816

Female, n/N (%)

90/199 (45.2)

142/263 (54.0)

658/1328 (49.5)

890/1790 (49.7)

Age, median [IQR]

67 [49–79]

75 [58–84]

72 [56–81]

72 [55–81]

Place of acquisition, n (%)

 Community

184 (93.9)

250 (95.1)

1354 (100)

1788 (98.4)

 Nursing home

12 (6.1)

11 (4.2)

0 (0)

23 (1.3)

 Hospital

0 (0)

2 (0.8)

0 (0)

2 (0.1)

Final diagnosis, n (%)

 Urinary tract infection

34 (17.1)

38 (14.6)

249 (18.4)

321 (17.7)

 Pneumonia/LRT

33 (16.6)

158 (60.5)

295 (21.8)

486 (26.8)

 Skin/soft tissue infection

14 (7.0)

10 (3.8)

149 (11.0)

173 (9.5)

 Abdominal infection

30 (15.1)

0 (0)

84 (6.2)

114 (6.3)

 Other infection

31 (15.6)

8 (3.1)

381 (28.1)

420 (23.1)

 Non-infectious

57 (28.6)

49 (18.6)

196 (14.5)

302 (16.6)

Outcomes, n (%)

 Positive blood culture

  Bacteraemia

13 (6.5)

18 (6.8)

126 (9.3)

157 (8.7)

  Contaminant

15 (7.5)

5 (1.9)

65 (4.8)

85 (4.7)

 30-day mortality

13 (6.5)

23 (8.7)

155 (11.4)

191 (10.5)